Akari Therapeutics Files Initial Beneficial Ownership Statement for Chief Business Officer Vatnak Vat-Ho

• Akari Therapeutics filed an initial statement of beneficial ownership for Chief Business Officer Vatnak Vat-Ho.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Akari Therapeutics plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-047057), on October 14, 2026, and is solely responsible for the information contained therein.